具有抗炎性能的双网基凝贴片,可有效防止腹膜粘附
Yangrui Du1, Li Ma1, Shiying Lang1
1College of Biomass Science and Engineering, Sichuan University, Chengdu 610065, China. lgy3506@scu.edu.cn.
Journal of materials chemistry. B
|September 5, 2025
概括
一个新的双网络水凝贴片 (GPSB) 通过结合凝和多硫贝 (PSB) 网络有效地预防术后腹膜粘附. 这种创新生物材料具有抗菌和抗炎性质,
科学领域:
- 生物材料科学
- 复原医学
- 外科创新
背景情况:
- 在腹部手术后,腹膜粘附是常见的并发症,导致显著的发病率.
- 目前的粘附预防策略存在局限性,需要开发新的解决方案.
研究的目的:
- 开发和评估双网络水凝贴片 (GPSB) 以有效预防术后腹膜粘附.
- 研究GPSB水凝的抗菌,抗炎和机械性能.
主要方法:
- 通过相互透的凝和聚硫乙烯 (PSB) 网络制造双网络水凝.
- 使用离子-多协调的凝网络的动态交联.
- 在凝矩阵内的PSB网络的现场聚合.
- 评估机械性能 (模,切割强度) 和蛋白质吸附阻力.
- 对抗菌活性和巨介导炎症反应的评估.
主要成果:
- GPSB水凝具有增强的机械完整性,Young的模量为97.7±5.2kPa,切削强度为28.5kPa.
- 该PSB成分显著降低了非特异性蛋白质吸附 (46倍) 和炎症性细胞因子分泌 (约2倍). 70%) 的情况.
- 在临床前模型中,水凝表现出固有的抗菌和治疗作用,以及有效的腹膜粘附预防作用.
结论:
- GPSB双网络水凝贴片是一种有前途的多功能生物材料,用于预防术后腹膜粘附.
- 它的协同抗菌和抗炎特性提供了强大的预防手术并发症.
- 这项研究提供了下一代抗粘附生物材料,具有临床转化潜力.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
1.4K
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.4K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
1.3K
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.3K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
2.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.3K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.7K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
1.0K
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
1.0K
Peptic Ulcer Disease IV: Management
807
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
807


